ENDOG and B-cell chronic lymphocytic leukemia: In this context, we decided to investigate the potential role of ENDOG in tumor cell proliferation using different in vitro and in vivo cellular models and its potential clinical impact in CLL, which has an activated PI3K-PKB/AKT pathway in relation with their PTEN status.